U.S. Army Medical Department journal
-
Although hemostatic agents may be effective at stopping hemorrhage, they may fail because of hemodilution from intravenous fluids. The purpose of this study was to investigate the effects of QuikClot Combat Gauze (QCG) on rebleeding in a class II hemorrhage in the presence of hemodilution in a lethal femoral injury. ⋯ QCG produces a robust clot that can more effectively tolerate hemodilution compared to a control group.
-
The purpose of this study was to examine the effectiveness of the hemostatic agent BleedArrest compared to control. This was a prospective, experimental design employing an established porcine model of uncontrolled hemorrhage. The minimum number of animals (n=10 per group) was used to obtain a statistically valid result. ⋯ There were significant differences in the amount of hemorrhage (P=.033) between the BleedArrest (mean=72, SD±72 mL) and control (mean=317.30, SD±112.02 mL). BleedArrest is statistically and clinically superior at controlling hemorrhage compared to the standard pressure dressing control group. In conclusion, BleedArrest is an effective hemostatic agent for use in civilian and military trauma management.
-
Medical evacuation has changed form the experiences of the past decade of combat operations. Much of the focus of the medical support in the combat zone is now critical care during evacuation, which is, and will continue to be, a very successful, life-saving asset. ⋯ It is time to upgrade the system of evacuation and provide our Warriors with the greatest possibilities of survival. Army nurses trained in critical care and trauma nursing are best suited to provide that continuity of care.